The vasodilating effect of acetazolamide and dorzolamide involves mechanisms other than carbonic anhydrase inhibition

Invest Ophthalmol Vis Sci. 2009 Jan;50(1):345-51. doi: 10.1167/iovs.08-2435. Epub 2008 Aug 29.

Abstract

Purpose: Carbonic anhydrase inhibitors reduce intraocular pressure, which may protect the optic nerve from ischemia. However, carbonic anhydrase inhibitors have also been shown to dilate the blood vessels in the retina and the optic nerve head. The purpose of the present study was to investigate whether CO(2), H(+), or factors other than carbonic anhydrase inhibition are involved in this vasodilating effect.

Methods: Porcine retinal arterioles with preserved perivascular retinal tissue were mounted in a myograph for isometric force measurements. After precontraction with the prostaglandin analogue U46619, concentration-response experiments were performed with acetazolamide and dorzolamide before and after removal of the perivascular retina. The experiments were performed at normal pH and during acidosis, during normocapnia and hypercapnia, as well as in the nominal absence of CO(2) and HCO(3)(-).

Results: The maximum relaxation was significantly lower and the EC(50) significantly higher during normal pH compared with acidosis (P = 0.002 and P < 0.0001, respectively), but neither the maximum relaxation nor EC(50) was changed by hypercapnia (P = 0.054 and P = 0.57, respectively). The findings confirmed that carbonic anhydrase-induced vasodilation depends on the perivascular retinal tissue and that dorzolamide produces significantly more pronounced relaxation than does acetazolamide. EC(50) of carbonic anhydrase inhibitor-induced vasorelaxation and the maximum relaxation of dorzolamide were unchanged in the nominal absence of CO(2) and HCO(3)(-) (P = 0.65 and P < 0.0001, respectively).

Conclusions: The vasodilating effect of carbonic anhydrase inhibitors on porcine retinal arterioles depends on the perivascular retinal tissue and acidosis, but not on hypercapnia. The effect involves mechanisms other than carbonic anhydrase inhibition.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid / pharmacology
  • Acetazolamide / pharmacology*
  • Acidosis / metabolism
  • Animals
  • Arterioles / physiology
  • Carbon Dioxide / pharmacology
  • Carbonic Anhydrase Inhibitors / pharmacology*
  • Carbonic Anhydrases / physiology*
  • Dose-Response Relationship, Drug
  • Hydrogen-Ion Concentration
  • Hypercapnia / metabolism
  • Muscle, Smooth, Vascular / drug effects*
  • Myography
  • Nifedipine / pharmacology
  • Retinal Artery / physiology*
  • Sulfonamides / pharmacology*
  • Swine
  • Thiophenes / pharmacology*
  • Vasoconstrictor Agents / pharmacology
  • Vasodilation / physiology*
  • Vasodilator Agents / pharmacology

Substances

  • Carbonic Anhydrase Inhibitors
  • Sulfonamides
  • Thiophenes
  • Vasoconstrictor Agents
  • Vasodilator Agents
  • Carbon Dioxide
  • 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid
  • dorzolamide
  • Carbonic Anhydrases
  • Nifedipine
  • Acetazolamide